Newronika Receives Investigational Device Exemption from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System

Newronika Spain Germany France United States of America Italy New York

or follow us on LinkedIn.

Logo - https://mma.prnewswire.com/media/2612569/5150136/Newronika_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/newronika-receives-investigational-device-exemption-ide-from-fda-to-initiate-us-clinical-trial-of-adaptive-dbs-system-302368037.html